DBV Technologies | Zysk Brutto

Cena Akcji
21.14
Dzienna Zmiana
-0.32 -1.49%
Miesięcznie
-2.45%
Rocznie
381.00%
Q1 Prognozy TE
20.91




Zysk Brutto Zmiana Data
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amarin USD -8.12M 5.34M 2025-09
BioCryst Pharmaceuticals USD -86.95M 73.5M 2024-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
DBV Technologies USD -33.16M 8.6M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Galectin Therapeutics USD -12.37M 880K 2024-06
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Incyte USD 389.94M 92.37M 2025-12
Insmed USD -326.93M 41.77M 2025-12
Ionis Pharmaceuticals USD -129M 253M 2025-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
United Therapeutics USD 438M 29.6M 2025-09


DBV Technologies Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.